HR 5444
Lower Insulin Costs Now Act
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
The Lower Insulin Costs Now Act aims to ensure continued review of certain insulin applications that were submitted before March 2020 and not yet approved by the FDA. It seeks to streamline the transition of these products to a ‘licensed’ biological product status, clarifying the process and timeline for approvals. The bill also addresses the listing of drugs and exclusivity periods to maintain clarity and prevent delays in accessing affordable insulin.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Andy Levin
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.